These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23213138)

  • 1. Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.
    Chen F; Ghosh A; Shneider BL
    J Lipid Res; 2013 Feb; 54(2):379-85. PubMed ID: 23213138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor.
    Frankenberg T; Miloh T; Chen FY; Ananthanarayanan M; Sun AQ; Balasubramaniyan N; Arias I; Setchell KD; Suchy FJ; Shneider BL
    Hepatology; 2008 Dec; 48(6):1896-905. PubMed ID: 18668687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATPase Class I Type 8B Member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes.
    Chen F; Ellis E; Strom SC; Shneider BL
    Pediatr Res; 2010 Feb; 67(2):183-7. PubMed ID: 19809379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
    Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
    Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
    Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
    Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
    Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
    J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.
    Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ
    J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
    Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
    Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
    Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
    J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1.
    Ananthanarayanan M; Li S; Balasubramaniyan N; Suchy FJ; Walsh MJ
    J Biol Chem; 2004 Dec; 279(52):54348-57. PubMed ID: 15471871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
    Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
    Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
    Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD
    J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis.
    Ananthanarayanan M; Li Y; Surapureddi S; Balasubramaniyan N; Ahn J; Goldstein JA; Suchy FJ
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G771-81. PubMed ID: 21330447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
    Colombo C; Okolicsanyi L; Strazzabosco M
    Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
    Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
    Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.